Specialty Treatments
View our innovative and evidence-based specialty treatments designed to address unique challenges and promote lasting healing and growth.
What are Specialty Treatments?
Specialty treatments include innovative and rapid-acting approaches for difficult-to-treat depression, such as Spravato® (intranasal esketamine) and Transcranial Magnetic Stimulation, as well as approved treatments to address many additional mental health conditions.
Specialty treatments often provide unique benefits and can be administered in different settings. LifeStance offers a diverse range of specialty treatments, aimed at giving individuals access to the latest therapeutic options.
Each of these specialty treatments offers unique potential benefits, often improving the quality of life for those grappling with specific mental health challenges. While some of these treatments can be conducted remotely or in an outpatient setting, others, such as Spravato®, Ketamine therapy, and TMS therapy require in-person administration due to safety and monitoring requirements.
Specialty treatments include innovative and rapid-acting approaches for difficult-to-treat depression, such as Spravato® (intranasal esketamine) and Transcranial Magnetic Stimulation, as well as approved treatments to address many additional mental health conditions.
Specialty treatments often provide unique benefits and can be administered in different settings. LifeStance offers a diverse range of specialty treatments, aimed at giving individuals access to the latest therapeutic options.
Each of these specialty treatments offers unique potential benefits, often improving the quality of life for those grappling with specific mental health challenges. While some of these treatments can be conducted remotely or in an outpatient setting, others, such as Spravato®, Ketamine therapy, and TMS therapy require in-person administration due to safety and monitoring requirements.
What are Specialty Treatments?
What are Specialty Treatments?
Specialty treatments include innovative and rapid-acting approaches for difficult-to-treat depression, such as Spravato® (intranasal esketamine) and Transcranial Magnetic Stimulation, as well as approved treatments to address many additional mental health conditions.
Specialty treatments often provide unique benefits and can be administered in different settings. LifeStance offers a diverse range of specialty treatments, aimed at giving individuals access to the latest therapeutic options.
Each of these specialty treatments offers unique potential benefits, often improving the quality of life for those grappling with specific mental health challenges. While some of these treatments can be conducted remotely or in an outpatient setting, others, such as Spravato®, Ketamine therapy, and TMS therapy require in-person administration due to safety and monitoring requirements.
Specialty Treatment Services
Ketamine Therapy
Ketamine is an FDA-approved anesthetic agent that can be used as an in-office, medically monitored treatment for depression.
Spravato® Treatment
Find hope for depression with Spravato® esketamine treatment. Explore fast-acting options and take the next step toward feeling better today.
TMS Therapy
If you have depression, but medication and therapy have not worked, this in-person treatment may be right for you.
Rachel Dalthorp, MD, is the Executive Medical Director of Specialty Services at LifeStance Health, where she leads clinical programming and innovation in reproductive psychiatry, interventional psychiatry and the treatment of complex mental health needs. She is a board-certified psychiatrist through the American Board of Psychiatry and Neurology. She earned her medical degree from the University of Oklahoma College of Medicine and completed a four-year psychiatry residency at the University of Oklahoma Health Sciences Center, where developed expertise on the assessment and treatment of mood disorders related to the female reproductive cycle. Dr. Dalthorp also completed specialized training in the treatment of female sexual disorders and the use of psychedelic medications for depression. Dr. Dalthorp is the President of the Oklahoma Psychiatric Physicians Association and a Distinguished Fellow of the American Psychiatric Association. She is a former board member of the American Association of Ketamine Physicians and currently volunteers as an Assistant Professor of Psychiatry at the University of Oklahoma Health Sciences Center. Additionally, she is a founding member of the International Society of Reproductive Psychiatry, a nonprofit organization created to advocate for reproductive psychiatry education and improved access to services for patients. Dr. Dalthorp, her husband Bo, their three sons, two cats and golden retriever live in Norman, Oklahoma. She enjoys spending time with family and friends, going to estate sales with her mom Jane and upcycling vintage furniture and junk.
